Cargando…
Anti-Cyclic Citrullinated Peptide Antibody-Positive Meningoencephalitis in the Preclinical Period of Rheumatoid Arthritis
Rheumatoid meningoencephalitis (RM) is a rare complication of rheumatoid arthritis (RA). This report describes a 63-year-old man with complaints of high-grade fever, headache, and vomiting for several days before admission. Both his serum and cerebrospinal fluid were positive for anti-cyclic citrull...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043166/ https://www.ncbi.nlm.nih.gov/pubmed/27721779 http://dx.doi.org/10.1159/000447627 |
_version_ | 1782456699401011200 |
---|---|
author | Shibahara, Tomoya Matsushita, Tomonaga Matsuo, Ryu Fukushima, Yoshihisa Fukuda, Kenji Sugimori, Hiroshi Kamouchi, Masahiro Kitazono, Takanari Ago, Tetsuro |
author_facet | Shibahara, Tomoya Matsushita, Tomonaga Matsuo, Ryu Fukushima, Yoshihisa Fukuda, Kenji Sugimori, Hiroshi Kamouchi, Masahiro Kitazono, Takanari Ago, Tetsuro |
author_sort | Shibahara, Tomoya |
collection | PubMed |
description | Rheumatoid meningoencephalitis (RM) is a rare complication of rheumatoid arthritis (RA). This report describes a 63-year-old man with complaints of high-grade fever, headache, and vomiting for several days before admission. Both his serum and cerebrospinal fluid were positive for anti-cyclic citrullinated peptide (CCP) antibody and rheumatoid factor, and contrast-enhanced fluid-attenuated inversion recovery magnetic resonance imaging (MRI) showed abnormal gadolinium enhancement of the meninges and high-intensity lesions in the subarachnoid spaces. The patient was diagnosed with RM despite lack of signs suggesting RA. His symptoms drastically improved with intravenous infusion of high-dose methylprednisolone. Two months later, he developed RA. The findings in this patient suggest that RM could develop prior to the onset of RA. Anti-CCP antibody and MRI findings may be useful for the diagnosis of RM, regardless of RA history. |
format | Online Article Text |
id | pubmed-5043166 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-50431662016-10-07 Anti-Cyclic Citrullinated Peptide Antibody-Positive Meningoencephalitis in the Preclinical Period of Rheumatoid Arthritis Shibahara, Tomoya Matsushita, Tomonaga Matsuo, Ryu Fukushima, Yoshihisa Fukuda, Kenji Sugimori, Hiroshi Kamouchi, Masahiro Kitazono, Takanari Ago, Tetsuro Case Rep Neurol Case Report Rheumatoid meningoencephalitis (RM) is a rare complication of rheumatoid arthritis (RA). This report describes a 63-year-old man with complaints of high-grade fever, headache, and vomiting for several days before admission. Both his serum and cerebrospinal fluid were positive for anti-cyclic citrullinated peptide (CCP) antibody and rheumatoid factor, and contrast-enhanced fluid-attenuated inversion recovery magnetic resonance imaging (MRI) showed abnormal gadolinium enhancement of the meninges and high-intensity lesions in the subarachnoid spaces. The patient was diagnosed with RM despite lack of signs suggesting RA. His symptoms drastically improved with intravenous infusion of high-dose methylprednisolone. Two months later, he developed RA. The findings in this patient suggest that RM could develop prior to the onset of RA. Anti-CCP antibody and MRI findings may be useful for the diagnosis of RM, regardless of RA history. S. Karger AG 2016-07-20 /pmc/articles/PMC5043166/ /pubmed/27721779 http://dx.doi.org/10.1159/000447627 Text en Copyright © 2016 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission. |
spellingShingle | Case Report Shibahara, Tomoya Matsushita, Tomonaga Matsuo, Ryu Fukushima, Yoshihisa Fukuda, Kenji Sugimori, Hiroshi Kamouchi, Masahiro Kitazono, Takanari Ago, Tetsuro Anti-Cyclic Citrullinated Peptide Antibody-Positive Meningoencephalitis in the Preclinical Period of Rheumatoid Arthritis |
title | Anti-Cyclic Citrullinated Peptide Antibody-Positive Meningoencephalitis in the Preclinical Period of Rheumatoid Arthritis |
title_full | Anti-Cyclic Citrullinated Peptide Antibody-Positive Meningoencephalitis in the Preclinical Period of Rheumatoid Arthritis |
title_fullStr | Anti-Cyclic Citrullinated Peptide Antibody-Positive Meningoencephalitis in the Preclinical Period of Rheumatoid Arthritis |
title_full_unstemmed | Anti-Cyclic Citrullinated Peptide Antibody-Positive Meningoencephalitis in the Preclinical Period of Rheumatoid Arthritis |
title_short | Anti-Cyclic Citrullinated Peptide Antibody-Positive Meningoencephalitis in the Preclinical Period of Rheumatoid Arthritis |
title_sort | anti-cyclic citrullinated peptide antibody-positive meningoencephalitis in the preclinical period of rheumatoid arthritis |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043166/ https://www.ncbi.nlm.nih.gov/pubmed/27721779 http://dx.doi.org/10.1159/000447627 |
work_keys_str_mv | AT shibaharatomoya anticycliccitrullinatedpeptideantibodypositivemeningoencephalitisinthepreclinicalperiodofrheumatoidarthritis AT matsushitatomonaga anticycliccitrullinatedpeptideantibodypositivemeningoencephalitisinthepreclinicalperiodofrheumatoidarthritis AT matsuoryu anticycliccitrullinatedpeptideantibodypositivemeningoencephalitisinthepreclinicalperiodofrheumatoidarthritis AT fukushimayoshihisa anticycliccitrullinatedpeptideantibodypositivemeningoencephalitisinthepreclinicalperiodofrheumatoidarthritis AT fukudakenji anticycliccitrullinatedpeptideantibodypositivemeningoencephalitisinthepreclinicalperiodofrheumatoidarthritis AT sugimorihiroshi anticycliccitrullinatedpeptideantibodypositivemeningoencephalitisinthepreclinicalperiodofrheumatoidarthritis AT kamouchimasahiro anticycliccitrullinatedpeptideantibodypositivemeningoencephalitisinthepreclinicalperiodofrheumatoidarthritis AT kitazonotakanari anticycliccitrullinatedpeptideantibodypositivemeningoencephalitisinthepreclinicalperiodofrheumatoidarthritis AT agotetsuro anticycliccitrullinatedpeptideantibodypositivemeningoencephalitisinthepreclinicalperiodofrheumatoidarthritis |